Authors/Disclosures
|
|
No disclosure on file |
|
Daniel Kantor, MD, FÂ鶹´«Ã½Ó³»
(Medical Partnership 4 MS+)
|
Dr. Kantor has received personal compensation for serving as an employee of Gateway Institute for Brain Research. Dr. Kantor has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Kantor has a non-compensated relationship as a HAP with MSFous (MSF) that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Kantor has a non-compensated relationship as a Medical Board with MS Views & News that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
|
Richard M. Dubinsky, MD, MPH, FÂ鶹´«Ã½Ó³»
(University of Kansas Medical Center)
|
Dr. Dubinsky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie Pharmaceuticals. An immediate family member of Dr. Dubinsky has stock in Abbvie and Abbott Labs. The institution of Dr. Dubinsky has received research support from CHDI. The institution of Dr. Dubinsky has received research support from Prilenia. The institution of Dr. Dubinsky has received research support from Sage Pharmaceuticals. The institution of Dr. Dubinsky has received research support from NIH/NINDS. Dr. Dubinsky has a non-compensated relationship as a Member, independent data safety monitoring board with Roche that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
|
|
No disclosure on file |
|
John Ko, PharmD, MS
(Alnylam)
|
Dr. Ko has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Ko has received personal compensation for serving as an employee of Novartis. Dr. Ko has received stock or an ownership interest from Alnylam Pharmaceuticals. Dr. Ko has received stock or an ownership interest from Novartis. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |